enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [ 1 ] [ 2 ] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.

3. Doctors Explain What Prostate Cancer Screenings Involve

   www.aol.com/doctors-explain-prostate-cancer...

   Prostate cancer is the second most common cause of cancer death among men, according to the American Cancer Society. This year, the organization projects that about 300,000 new cases will be ...

4. United States Preventive Services Task Force - Wikipedia

   en.wikipedia.org/wiki/United_States_Preventive...

   In the current recommendation published in 2018, the Task Force recommended that prostate-specific antigen (PSA)-based screening for prostate cancer screenings be an individual decision for men between the ages of 55 and 69. [18] In 2018 the Task Force gave PCa screening a C recommendation. [18]

5. 10 Warning Signs of Prostate Cancer, According to Doctors - AOL

   www.aol.com/10-warning-signs-prostate-cancer...

   What does prostate cancer screening involve? Prostate cancer screening typically involves two tests, Dr. Spratt says. One is a digital rectal exam, where doctors feel the prostate gland for ...

6. Prostate cancer screening: the decision is up to you - AOL

   www.aol.com/news/prostate-cancer-screening...

   By Will Boggs MD (Reuters Health) - Men aged 55 to 69 years should be informed of the possible benefits and harms of prostate cancer screening and then make their own decision on whether or not to ...

7. Active surveillance of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Active_surveillance_of...

   In a separate study of men from the pre prostate cancer screening era managed with watchful waiting (56% over age 70 years), progression to distant metastasis or prostate cancer death was 13.9% and 12.3%, respectively for Gleason score 6 or below, but considerably higher at 18.2 and 22.7%, 30% and 20%, 44.4% and 55.6% for Gleason 3+4, 4+3, and ...